Reply to thread

Message: [QUOTE="greenmedinfo, post: 3262"] PMID: Immunol Lett. 2020 12 ;228:45-54. Epub 2020 Oct 7. PMID: 33035575 Abstract Title: Psychedelics as a novel approach to treating autoimmune conditions. Abstract: With a rise in the incidence of autoimmune diseases (AiD), health care providers continue to seek out more efficacious treatment approaches for the AiD patient population. Classic serotonergic psychedelics have recently been gaining public and professional interest as novel interventions to a number of mental health afflictions. Psychedelics have also been shown to be able to modulate immune functions, however, while there has been great interest to researching into their psychotherapeutic applications, there has so far been very little exploration into the potential to treat inflammatory and immune-related diseases with these compounds. A handful of studies from a variety of fields suggest that psychedelics do indeed have effects in the body that may attenuate the outcome of AiD. This literature review explores existing evidence that psychedelic compounds may offer a potential novel application in the treatment of pathologies related to autoimmunity. We propose that psychedelics hold the potential to attenuate or even resolve autoimmunity by targeting psychosomatic origins, maladaptive chronic stress responses, inflammatory pathways, immune modulation and enteric microbiome populations. [URL='https://www.greenmedinfo.com/article/psychedelics-novel-approach-treating-autoimmune-conditions']read more[/URL] [/QUOTE]

Verification

Top Bottom

Search

Search

Reply to thread